Youcare Pharmaceutical Group Co. Ltd. Class ASSE: 688658

Announcement on Voluntary Disclosure of YKYY017 Aerosol Inhalation Formulation Receiving FDA Clinical Trial Approval for the Indication of Prophylaxis and Treatment of Coronavirus-Associated Respiratory Infections

· Issued by Youcare Pharmaceutical Group Co. Ltd. Class A via Shanghai Stock Exchange

On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-ykyy017-aerosol-inhalation-formulation-receiving-fda-clinical-trial-approval-for-the-indication-of-prophylaxis-and-treatment-of-coronavirus-associated-respiratory-infections

Announcement on Voluntary Disclosure of YKYY017 Aerosol Inhalation Formulation Receiving FDA Clinical Trial Approval for the Indication of Prophylaxis and Treatment of Coronavirus-Associated Respiratory Infections

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Youcare Pharmaceutical Group Co. Ltd. Class A

All Youcare Pharmaceutical Group Co. Ltd. Class A news releases